Annual report pursuant to Section 13 and 15(d)

DERIVATIVE LIABILITY (Details Narrative)

v3.22.0.1
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Gain (Loss) on Sale of Derivatives $ 663,290 $ (251,000)  
Loan Agreement [Member] | K2 HealthVentures LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Secured debt 21,190,000   $ 50,000,000
Initial measurement of fair value 133,710 $ 797,000  
Gain (Loss) on Sale of Derivatives $ 663,290    
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Secured debt     $ 20,000,000